Brief: Phio Pharmaceuticals Reports Q3 Loss Per Share Of $0.40
10/11/2020 22:57
Nov 10 (Reuters) - Phio Pharmaceuticals Corp PHIO.O :
* PHIO PHARMACEUTICALS REPORTS THIRD QUARTER 2020 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* Q3 LOSS PER SHARE $0.40
* EXPECTS CASH WILL BE SUFFICIENT TO FUND CURRENTLY PLANNED
OPERATIONS FOR AT LEAST NEXT 12 MONTHS
* ENDED QUARTER WITH TOTAL CASH OF APPROXIMATELY $16.9
MILLION AS
OF SEPTEMBER 30, 2020
Source text for Eikon: ID:nPn3zbXdra
Further company coverage: PHIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Phio Pharmaceuticals
See all newsPhio Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: Phio Pharmaceuticals Corp - Enters At The Market Offering Agreement With H.C. Wainwright On April 8, 2026
Brief: Phio Pharmaceuticals Corp Announces Key Tumor Response Data From PH-762 Trial
Brief: Phio Pharmaceuticals Corp To Begin Toxicology Study For Ph-762 Before Human Trials - SEC Filing
Brief: Phio Pharmaceuticals Corp Files For Offering Of Up To 11.8 Million Common Shares By The Selling Stockholders - SEC Filing